These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 11559529)
1. Accumulation of beta-catenin protein and mutations in exon 3 of beta-catenin gene in gastrointestinal carcinoid tumor. Fujimori M; Ikeda S; Shimizu Y; Okajima M; Asahara T Cancer Res; 2001 Sep; 61(18):6656-9. PubMed ID: 11559529 [TBL] [Abstract][Full Text] [Related]
2. Nuclear translocation of beta-catenin protein but absence of beta-catenin and APC mutation in gastrointestinal carcinoid tumor. Su MC; Wang CC; Chen CC; Hu RH; Wang TH; Kao HL; Jeng YM; Yuan RH Ann Surg Oncol; 2006 Dec; 13(12):1604-9. PubMed ID: 17009161 [TBL] [Abstract][Full Text] [Related]
3. Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway. Torbenson M; Lee JH; Choti M; Gage W; Abraham SC; Montgomery E; Boitnott J; Wu TT Mod Pathol; 2002 Mar; 15(3):189-96. PubMed ID: 11904335 [TBL] [Abstract][Full Text] [Related]
4. Frequent alterations of the beta-catenin and TCF-4 genes, but not of the APC gene, in colon cancers with high-frequency microsatellite instability. Fukushima H; Yamamoto H; Itoh F; Horiuchi S; Min Y; Iku S; Imai K J Exp Clin Cancer Res; 2001 Dec; 20(4):553-9. PubMed ID: 11876551 [TBL] [Abstract][Full Text] [Related]
5. P53 gene and Wnt signaling in benign neoplasms: beta-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Chen YW; Jeng YM; Yeh SH; Chen PJ Hepatology; 2002 Oct; 36(4 Pt 1):927-35. PubMed ID: 12297840 [TBL] [Abstract][Full Text] [Related]
6. beta-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Clements WM; Wang J; Sarnaik A; Kim OJ; MacDonald J; Fenoglio-Preiser C; Groden J; Lowy AM Cancer Res; 2002 Jun; 62(12):3503-6. PubMed ID: 12067995 [TBL] [Abstract][Full Text] [Related]
7. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors. Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927 [TBL] [Abstract][Full Text] [Related]
8. Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules. Nakatani Y; Masudo K; Miyagi Y; Inayama Y; Kawano N; Tanaka Y; Kato K; Ito T; Kitamura H; Nagashima Y; Yamanaka S; Nakamura N; Sano J; Ogawa N; Ishiwa N; Notohara K; Resl M; Mark EJ Mod Pathol; 2002 Jun; 15(6):617-24. PubMed ID: 12065775 [TBL] [Abstract][Full Text] [Related]
9. WNT-1 expression in basal cell carcinoma of head and neck. An immunohistochemical and confocal study with regard to the intracellular distribution of beta-catenin. Lo Muzio L; Pannone G; Staibano S; Mignogna MD; Grieco M; Ramires P; Romito AM; De Rosa G; Piattelli A Anticancer Res; 2002; 22(2A):565-76. PubMed ID: 12014624 [TBL] [Abstract][Full Text] [Related]
10. Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Stancu M; Wu TT; Wallace C; Houlihan PS; Hamilton SR; Rashid A Mod Pathol; 2003 Dec; 16(12):1189-98. PubMed ID: 14681318 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis and mutational analyses of beta-catenin, Axin family and APC genes in hepatocellular carcinomas. Ishizaki Y; Ikeda S; Fujimori M; Shimizu Y; Kurihara T; Itamoto T; Kikuchi A; Okajima M; Asahara T Int J Oncol; 2004 May; 24(5):1077-83. PubMed ID: 15067328 [TBL] [Abstract][Full Text] [Related]
12. Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. Taniguchi K; Roberts LR; Aderca IN; Dong X; Qian C; Murphy LM; Nagorney DM; Burgart LJ; Roche PC; Smith DI; Ross JA; Liu W Oncogene; 2002 Jul; 21(31):4863-71. PubMed ID: 12101426 [TBL] [Abstract][Full Text] [Related]
13. Beta-catenin mutations in hepatocellular carcinoma correlate with a low rate of loss of heterozygosity. Legoix P; Bluteau O; Bayer J; Perret C; Balabaud C; Belghiti J; Franco D; Thomas G; Laurent-Puig P; Zucman-Rossi J Oncogene; 1999 Jul; 18(27):4044-6. PubMed ID: 10435629 [TBL] [Abstract][Full Text] [Related]
14. APC mutations are infrequent but present in human lung cancer. Ohgaki H; Kros JM; Okamoto Y; Gaspert A; Huang H; Kurrer MO Cancer Lett; 2004 Apr; 207(2):197-203. PubMed ID: 15072829 [TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Murakami T; Toda S; Fujimoto M; Ohtsuki M; Byers HR; Etoh T; Nakagawa H Biochem Biophys Res Commun; 2001 Oct; 288(1):8-15. PubMed ID: 11594745 [TBL] [Abstract][Full Text] [Related]
16. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma. Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377 [TBL] [Abstract][Full Text] [Related]
17. Frequent nuclear beta-catenin accumulation and associated mutations in endometrioid-type endometrial and ovarian carcinomas with squamous differentiation. Saegusa M; Okayasu I J Pathol; 2001 May; 194(1):59-67. PubMed ID: 11329142 [TBL] [Abstract][Full Text] [Related]
18. Mutational activation of the RAS-RAF-MAPK and the Wnt pathway in small intestinal adenocarcinomas. Bläker H; Helmchen B; Bönisch A; Aulmann S; Penzel R; Otto HF; Rieker RJ Scand J Gastroenterol; 2004 Aug; 39(8):748-53. PubMed ID: 15513360 [TBL] [Abstract][Full Text] [Related]
19. Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway. Fukuzawa R; Heathcott RW; Sano M; Morison IM; Yun K; Reeve AE Pediatr Dev Pathol; 2004; 7(2):125-37. PubMed ID: 14994125 [TBL] [Abstract][Full Text] [Related]
20. No evidence for involvement of beta-catenin and APC in urothelial carcinomas. Stoehr R; Krieg RC; Knuechel R; Hofstaedter F; Pilarsky C; Zaak D; Schmitt R; Hartmann A Int J Oncol; 2002 May; 20(5):905-11. PubMed ID: 11956582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]